All In MedTech

Device Trial Radar · NCT07923565

CANLINK: Evaluation of the Intralink Intradiscal Device for Low Back Pain Due to Degenerative Disc Disease

CANLINK: A Prospective Clinical Study Evaluating the Safety and Performance of the Intralink Intradiscal Device for Treatment of Low Back Pain From Degenerative Disc Disease

Last checked: Nov 19, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

40

Planned (sponsor's estimate)

Start

Jan 2027

Primary completion

Jul 2027

Study completion Jun 2029

Sponsor

Lead sponsor
Spinal Simplicity LLCNot on our public-company list
Sponsor type
Industry
First posted
Nov 6, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 22 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A single site, prospective study to evaluate the safety and performance of the Intralink device in participants with chronic or recurrent non-radicular discogenic low back pain (LBP) due to degenerative disc disease (DDD).

Conditions

  • Degenerative Disc Disease(DDD)

Interventions

  • Pain treatmentDevice

    Device: Intralink

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Oswestry Disability Index (ODI)Time frame: 1 Month compared to Baseline
  2. Assess occurrence of serious adverse events post-treatment.Time frame: Through 1 Month post procedure

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Beam Radiology

    Calgary, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.